These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21412393)

  • 21. Current concepts in clinical therapeutics: Parkinson's disease.
    Erwin WG; Turco TF
    Clin Pharm; 1986 Sep; 5(9):742-53. PubMed ID: 3530616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease.
    Constantino AE; Honig LS
    Sci Aging Knowledge Environ; 2001 Nov; 2001(7):dn4. PubMed ID: 14602969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability in the clinical expression of Parkinson's disease.
    Wolters ECh
    J Neurol Sci; 2008 Mar; 266(1-2):197-203. PubMed ID: 17854836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of Parkinson's disease genetics.
    Lorincz MT
    Semin Neurol; 2006 Nov; 26(5):492-8. PubMed ID: 17048150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and relation of dementia to various factors in Parkinson's disease.
    Rana AQ; Yousuf MS; Naz S; Qa'aty N
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):64-8. PubMed ID: 22250611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-motor dysfunction in Parkinson's disease.
    Ziemssen T; Reichmann H
    Parkinsonism Relat Disord; 2007 Aug; 13(6):323-32. PubMed ID: 17349813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.
    Lang AE
    Mov Disord; 2011 Apr; 26(5):775-83. PubMed ID: 21484865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease: clinical aspects.
    Klockgether T
    Cell Tissue Res; 2004 Oct; 318(1):115-20. PubMed ID: 15365814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical criteria for the diagnosis of Parkinson's disease.
    Reichmann H
    Neurodegener Dis; 2010; 7(5):284-90. PubMed ID: 20616563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The premotor phase of Parkinson's disease.
    Tolosa E; Compta Y; Gaig C
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S2-7. PubMed ID: 17681839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep dysfunction and role of dysautonomia in Parkinson's disease.
    Mitra T; Chaudhuri KR
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S93-5. PubMed ID: 20083018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does early detection of non-motor symptoms facilitate early treatment of Parkinson's disease?].
    Hasegawa K
    Brain Nerve; 2012 Apr; 64(4):453-61. PubMed ID: 22481518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
    Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
    Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The progression of pathology in Parkinson's disease.
    Halliday GM; McCann H
    Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.
    Parkkinen L; Kauppinen T; Pirttilä T; Autere JM; Alafuzoff I
    Ann Neurol; 2005 Jan; 57(1):82-91. PubMed ID: 15562510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early diagnosis of Parkinson's disease and initiation of treatment.
    Weiner WJ
    Rev Neurol Dis; 2008; 5(2):46-53; quiz 54-5. PubMed ID: 18660736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease. Clinical and electrophysiological evaluation.
    Al-Bunyan MA
    Saudi Med J; 2000 Jan; 21(1):72-5. PubMed ID: 11533754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.